Literature DB >> 17424131

Meta-analysis of field trials of antimicrobial mass medication for prophylaxis of bovine respiratory disease in feedlot cattle.

J Van Donkersgoed.   

Abstract

One hundred and seven field trials of prophylactic mass medication for bovine respiratory disease (BRD) in feedlot cattle were reviewed. Meta-analysis is the formal quantitative statistical review process that was used to synthesize the data from randomized field trials and draw conclusions concerning the efficacy of prophylactic mass medication in feedlot calves.The results of the meta-analysis indicated that prophylactic parenteral mass medication of calves with long-acting oxytetracycline or tilmicosin on arrival at the feedlot would reduce BRD morbidity rates (p < 0.001). There were, however, unreliable data on the effects of mass medication on mortality rates and performance, insufficient data on the most effective treatment regimes, and no valid data on the efficacy of feed and water medication for prophylaxis of BRD.This review highlights the gaps in our knowledge and points out the need for additional well-designed randomized controlled field trials of adequate size to assess the efficacy and socioeconomic impact of prophylactic mass medication for BRD in feedlot cattle.

Entities:  

Year:  1992        PMID: 17424131      PMCID: PMC1481390     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  30 in total

Review 1.  The treatment and prevention of bovine pneumonic pasteurellosis using antimicrobial drugs.

Authors:  M K Shoo
Journal:  Vet Res Commun       Date:  1990       Impact factor: 2.459

2.  Prophylactic medication of feedlot calves with tilmicosin.

Authors:  F J Schumann; E D Janzen; J J McKinnon
Journal:  Vet Rec       Date:  1991-03-23       Impact factor: 2.695

3.  Problems and practice in mass medication of beef cattle.

Authors:  J H Pollreisz; D T Bechtol; D W Upson
Journal:  Vet Clin North Am Food Anim Pract       Date:  1991-11       Impact factor: 3.357

4.  Meta-analysis in the breech.

Authors:  C Mann
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

5.  Meta-analysis: science or religion?

Authors:  C L Meinert
Journal:  Control Clin Trials       Date:  1989-12

6.  Publication bias and clinical trials.

Authors:  K Dickersin; S Chan; T C Chalmers; H S Sacks; H Smith
Journal:  Control Clin Trials       Date:  1987-12

7.  Efficacy of immunization of feedlot calves with a commercial Haemophilus somnus bacterin.

Authors:  C S Ribble; G K Jim; E D Janzen
Journal:  Can J Vet Res       Date:  1988-04       Impact factor: 1.310

8.  Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Authors:  S Yusuf; R Peto; J Lewis; R Collins; P Sleight
Journal:  Prog Cardiovasc Dis       Date:  1985 Mar-Apr       Impact factor: 8.194

Review 9.  Abnormal mitral valve motion associated with ventricular septal defect following acute myocardial infarction.

Authors:  R Rosenthal; J J Kleid; M V Cohen
Journal:  Am Heart J       Date:  1979-11       Impact factor: 4.749

10.  Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-30
View more
  10 in total

1.  Associations between antimicrobial use and the prevalence of antimicrobial resistance in fecal Escherichia coli from feedlot cattle in western Canada.

Authors:  Sylvia L Checkley; John R Campbell; Manuel Chirino-Trejo; Eugene D Janzen; Cheryl L Waldner
Journal:  Can Vet J       Date:  2010-08       Impact factor: 1.008

2.  A comparison of prophylactic efficacy of tilmicosin and a new formulation of oxytetracycline in feedlot calves.

Authors:  Oliver C Schunich; P Timothy Guichon; Calvin W Booker; G Kee Jim; Brian K Wildman; Bruce W Hill; Tracy I Ward; Stewart W Bauck; John A Jacobsen
Journal:  Can Vet J       Date:  2002-05       Impact factor: 1.008

Review 3.  The epidemiology of bovine respiratory disease: what is the evidence for preventive measures?

Authors:  Jared D Taylor; Robert W Fulton; Terry W Lehenbauer; Douglas L Step; Anthony W Confer
Journal:  Can Vet J       Date:  2010-12       Impact factor: 1.008

4.  Comparison of enrofloxacin and ceftiofur sodium for the treatment of relapse of undifferentiated fever/bovine respiratory disease in feedlot cattle.

Authors:  Sameeh M Abutarbush; Oliver C Schunicht; Brian K Wildman; Sherry J Hannon; G Kee Jim; Tracy I Ward; Calvin W Booker
Journal:  Can Vet J       Date:  2012-01       Impact factor: 1.008

5.  A comparison of the clinical field efficacy and safety of florfenicol and tilmicosin for the treatment of undifferentiated bovine respiratory disease of cattle in western Canada.

Authors:  B R Hoar; M D Jelinski; C S Ribble; E D Janzen; J C Johnson
Journal:  Can Vet J       Date:  1998-03       Impact factor: 1.008

6.  The occurrence of Haemophilus somnus in feedlot calves and its control by postarrival prophylactic mass medication.

Authors:  J Van Donkersgoed; E D Janzen; A A Potter; R J Harland
Journal:  Can Vet J       Date:  1994-09       Impact factor: 1.008

7.  Efficacy of a feed-additive antibacterial combination for improving feedlot cattle performance and health.

Authors:  G F Gallo; J L Berg
Journal:  Can Vet J       Date:  1995-04       Impact factor: 1.008

8.  The effect of route and dosage of immunization on the serological response to a Pasteurella haemolytica and Haemophilus somnus vaccine in feedlot calves.

Authors:  J Van Donkersgoed; F J Schumann; R J Harland; A A Potter; E D Janzen
Journal:  Can Vet J       Date:  1993-12       Impact factor: 1.008

9.  Scoping Review on Risk Factors and Methods for the Prevention of Bovine Respiratory Disease Applicable to Cow-Calf Operations.

Authors:  Shih-Yu Chen; Pedro Negri Bernardino; Erik Fausak; Megan Van Noord; Gabriele Maier
Journal:  Animals (Basel)       Date:  2022-01-29       Impact factor: 2.752

10.  Identification of novel drug targets in bovine respiratory disease: an essential step in applying biotechnologic techniques to develop more effective therapeutic treatments.

Authors:  Meena Kishore Sakharkar; Karthic Rajamanickam; Ramesh Chandra; Haseeb A Khan; Abdullah S Alhomida; Jian Yang
Journal:  Drug Des Devel Ther       Date:  2018-05-07       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.